propylene glycol has been researched along with betadex in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (23.81) | 18.2507 |
| 2000's | 9 (42.86) | 29.6817 |
| 2010's | 7 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beger-Hintzen, H; Doenicke, A; Hoernecke, R; Kugler, A; Nebauer, AE; Roizen, MF | 1 |
| Banga, AK; Chang, SL | 1 |
| Audus, KL; Foster, KA; Gupta, S; Medlicott, NJ; Stella, VJ | 1 |
| Ayres, JW; Cui, JH; Lee, BJ; Parrott, KA; Sack, RL | 1 |
| Arima, H; Hirano, M; Hirayama, F; Irie, T; Miyake, K; Okamaoto, Y; Uekama, K | 1 |
| Kobayashi, S; Kondo, H; Takahashi, Y; Watanabe, T; Yasuda, T; Yokohama, S | 1 |
| Chen, GB; Tang, KW | 1 |
| Headley, JV; Hill, GA; Purwaningsih, IS | 1 |
| Chang, RK; Shojaei, AH | 1 |
| McIntosh, MP; Rajewski, RA; Schwarting, N | 1 |
| Peppard, TL; Reineccius, GA; Reineccius, TA | 1 |
| He, Y; Tabibi, SE; Yalkowsky, SH | 1 |
| Goto, H; Kameyama, Y; McIntosh, MP; Narita, H; Rajewski, RA | 1 |
| Kubis, AA; Pluta, J; Szcześniak, M | 1 |
| Kopytek, S; McIntyre, B; Sherratt, P; Thackaberry, EA; Trouba, K | 1 |
| Enright, BP; Kopytek, SJ; McIntyre, BS; Thackaberry, EA; Treinen, KA | 1 |
| Balakrishnan, P; Cho, HJ; Choi, HG; Kim, DD; Song, CK; Yang, SG; Yong, CS | 1 |
| Hao, A; Hao, J; Hou, Y; Liu, W; Sun, T; Xin, F; Xing, P | 1 |
| Barenholz, Y; Cern, A; Goldblum, A; Nativ-Roth, E | 1 |
| Burdett, L; Cotton, P; Finney, R; Garner, C; Hargreaves, A; Harris, J; Healing, G; Kirk, S; Pivette, P; Schramm, C; Sulemann, T | 1 |
| Bergren, M; Chen, J; Mallik, R; Miller, T; Singh, R | 1 |
1 trial(s) available for propylene glycol and betadex
| Article | Year |
|---|---|
A comparison of two formulations for etomidate, 2-hydroxypropyl-beta-cyclodextrin (HPCD) and propylene glycol.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adult; beta-Cyclodextrins; Cyclodextrins; Double-Blind Method; Electroencephalography; Etomidate; Humans; Male; Propylene Glycol; Propylene Glycols; Solvents | 1994 |
20 other study(ies) available for propylene glycol and betadex
| Article | Year |
|---|---|
Transdermal iontophoretic delivery of hydrocortisone from cyclodextrin solutions.
Topics: Administration, Cutaneous; Anti-Inflammatory Agents; beta-Cyclodextrins; Cadaver; Chemistry, Pharmaceutical; Cyclodextrins; Humans; Hydrocortisone; Iontophoresis; Permeability; Pharmaceutical Vehicles; Propylene Glycol; Skin Physiological Phenomena; Solvents | 1998 |
Comparison of the effects of potential parenteral vehicles for poorly water soluble anticancer drugs (organic cosolvents and cyclodextrin solutions) on cultured endothelial cells (HUV-EC).
Topics: Antineoplastic Agents; beta-Cyclodextrins; Cells, Cultured; Citrates; Cyclodextrins; Drug Carriers; Endothelium; Ethanol; Humans; Propylene Glycol; Solvents; Umbilical Cord | 1998 |
Percutaneous absorption and model membrane variations of melatonin in aqueous-based propylene glycol and 2-hydroxypropyl-beta-cyclodextrin vehicles.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Topical; Animals; Antioxidants; beta-Cyclodextrins; Cyclodextrins; Diffusion; Excipients; Male; Melatonin; Mice; Mice, Hairless; Permeability; Pharmaceutical Vehicles; Propylene Glycol; Skin Absorption; Solubility | 1998 |
Characterization of itraconazole/2-hydroxypropyl-beta-cyclodextrin inclusion complex in aqueous propylene glycol solution.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Antifungal Agents; beta-Cyclodextrins; Cyclodextrins; Drug Stability; Itraconazole; Propylene Glycol; Solubility; Solutions | 1999 |
Common solubilizers to estimate the Caco-2 transport of poorly water-soluble drugs.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Caco-2 Cells; Cell Survival; Cyclodextrins; Dextrans; Excipients; Fluorescein-5-isothiocyanate; Humans; Intestinal Absorption; Nadolol; Permeability; Polyethylene Glycols; Polysorbates; Propranolol; Propylene Glycol; Solubility; Solvents | 2002 |
[Preparation of gas chromatographic capillary columns with beta-cyclodextrin polymer stationary phase modified with methyl phenyl silicone(OV-17)].
Topics: beta-Cyclodextrins; Chromatography, Gas; Cyclodextrins; Polymers; Propylene Glycol; Siloxanes; Stereoisomerism; Ultrasonics; Xylenes | 2000 |
Mass transfer and bioremediation of naphthalene particles in a roller bioreactor.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; beta-Cyclodextrins; Biodegradation, Environmental; Bioreactors; Catechols; Cyclodextrins; Kinetics; Naphthalenes; Oxygen; Propylene Glycol; Pseudomonas; Solubility; Water; Water Purification | 2004 |
Effect of hydroxypropyl beta-cyclodextrin on drug solubility in water-propylene glycol mixtures.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Carbamazepine; Chromatography, High Pressure Liquid; Chromatography, Liquid; Cyclodextrins; Drug Compounding; Excipients; Mass Spectrometry; Propylene Glycol; Solubility; Water | 2004 |
In vitro and in vivo evaluation of a sulfobutyl ether beta-cyclodextrin enabled etomidate formulation.
Topics: Adjuvants, Pharmaceutic; Animals; beta-Cyclodextrins; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Dogs; Drug Stability; Etomidate; Hemolysis; In Vitro Techniques; Injections, Intravenous; Injections, Subcutaneous; Male; Models, Biological; Pharmaceutical Solutions; Propylene Glycol; Solubility; Time Factors | 2004 |
The effect of solvent interactions on alpha-, beta-, and gamma-cyclodextrin/flavor molecular inclusion complexes.
Topics: alpha-Cyclodextrins; beta-Cyclodextrins; Citrates; Flavoring Agents; gamma-Cyclodextrins; Propylene Glycol; Solvents; Triacetin | 2005 |
Solubilization of two structurally related anticancer drugs: XK-469 and PPA.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Antineoplastic Agents; beta-Cyclodextrins; Chromatography, High Pressure Liquid; Ethanol; Hydrogen-Ion Concentration; Micelles; Polysorbates; Propionates; Propylene Glycol; Quinoxalines; Solubility; Solvents; Surface-Active Agents | 2006 |
Evaluation of mean arterial blood pressure, heart rate, and sympathetic nerve activity in rabbits after administration of two formulations of etomidate.
Topics: Animals; Area Under Curve; beta-Cyclodextrins; Blood Pressure; Etomidate; Heart Rate; Hypnotics and Sedatives; Male; Propylene Glycol; Prospective Studies; Rabbits; Random Allocation; Solubility; Solvents; Sympathetic Nervous System; Time Factors | 2007 |
The effect of hydrophilic base on pharmaceutical availability of prednisolone complexed with beta-cyclodextrin.
Topics: Acetamides; Anti-Inflammatory Agents; beta-Cyclodextrins; Biological Availability; Gels; Hydrogels; Pharmaceutical Vehicles; Polysorbates; Prednisolone; Propylene Glycol | 2007 |
Comprehensive investigation of hydroxypropyl methylcellulose, propylene glycol, polysorbate 80, and hydroxypropyl-beta-cyclodextrin for use in general toxicology studies.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Oral; Alanine Transaminase; Animals; Aspartate Aminotransferases; beta-Cyclodextrins; Diarrhea; Dogs; Female; Hypromellose Derivatives; Liver; Liver Function Tests; Macaca fascicularis; Male; Methylcellulose; Mice; Pharmaceutical Vehicles; Polysorbates; Propylene Glycol; Rats; Toxicity Tests | 2010 |
Assessment of hydroxypropyl methylcellulose, propylene glycol, polysorbate 80, and hydroxypropyl-β-cyclodextrin for use in developmental and reproductive toxicology studies.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Abnormalities, Drug-Induced; Animals; beta-Cyclodextrins; Dose-Response Relationship, Drug; Eating; Embryo, Mammalian; Female; Hypromellose Derivatives; Methylcellulose; Pharmaceutical Vehicles; Polysorbates; Pregnancy; Propylene Glycol; Rabbits; Rats; Reproduction; Toxicity Tests; Weight Gain | 2010 |
Inclusion complex effect on the bioavailability of clotrimazole from poloxamer-based solid suppository.
Topics: Administration, Rectal; Animals; Antifungal Agents; beta-Cyclodextrins; Biological Availability; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Clotrimazole; Drug Carriers; Hydrophobic and Hydrophilic Interactions; Male; Models, Chemical; Poloxamer; Powder Diffraction; Propylene Glycol; Rats; Rats, Sprague-Dawley; Solubility; Suppositories; Technology, Pharmaceutical | 2012 |
Novel double phase transforming organogel based on β-cyclodextrin in 1,2-propylene glycol.
Topics: beta-Cyclodextrins; Biocompatible Materials; Carbonates; Gels; Models, Molecular; Molecular Conformation; Phase Transition; Potassium; Propylene Glycol | 2012 |
Effect of solubilizing agents on mupirocin loading into and release from PEGylated nanoliposomes.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Acetates; Anti-Bacterial Agents; beta-Cyclodextrins; Calcium Compounds; Computer Simulation; Cryoelectron Microscopy; Drug Carriers; Drug Compounding; Drug Design; Drug Liberation; Excipients; Liposomes; Mupirocin; Nanostructures; Particle Size; Polyethylene Glycols; Propylene Glycol; Solubility; Surface Properties | 2014 |
Safety data on 19 vehicles for use in 1 month oral rodent pre-clinical studies: administration of hydroxypropyl-ß-cyclodextrin causes renal toxicity.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; beta-Cyclodextrins; Dimethyl Sulfoxide; Ethylene Glycols; Female; Kidney; Male; Organ Size; Pharmaceutical Vehicles; Poloxamer; Propylene Glycol; Rats; Triglycerides | 2016 |
Solution stability of Captisol-stabilized melphalan (Evomela) versus Propylene glycol-based melphalan hydrochloride injection.
Topics: Antineoplastic Agents, Alkylating; beta-Cyclodextrins; Drug Contamination; Drug Stability; Excipients; Injections; Melphalan; Pharmaceutical Solutions; Propylene Glycol | 2018 |